Publication: In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice
In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice
Date
Date
Date
Citations
Böck, D., Revers, I. M., Bomhof, A. S. J., Hillen, A. E. J., Boeijink, C., Kissling, L., Egli, S., Moreno-Mateos, M. A., van der Knaap, M. S., van Til, N. P., & Schwank, G. (2024). In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice. Molecular Therapy, 32(5), 1328–1343. https://doi.org/10.1016/j.ymthe.2024.03.009
Abstract
Abstract
Abstract
Vanishing white matter (VWM) is a fatal leukodystrophy caused by recessive mutations in subunits of the eukaryotic translation initiation factor 2B. Currently, there are no effective therapies for VWM. Here, we assessed the potential of adenine base editing to correct human pathogenic VWM variants in mouse models. Using adeno-associated viral vectors, we delivered intein-split adenine base editors into the cerebral ventricles of newborn VWM mice, resulting in 45.9% ± 5.9% correction of the Eif2b5$^{R191H}$ variant in the cortex. Treat
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Böck, D., Revers, I. M., Bomhof, A. S. J., Hillen, A. E. J., Boeijink, C., Kissling, L., Egli, S., Moreno-Mateos, M. A., van der Knaap, M. S., van Til, N. P., & Schwank, G. (2024). In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice. Molecular Therapy, 32(5), 1328–1343. https://doi.org/10.1016/j.ymthe.2024.03.009